Scientists Battle In Court Over Lucrative Patents For Gene-Editing Tool

A gene-editing technology called CRISPR-cas9 could be a gold mine for its inventors, but it's not clear who owns the idea. U.S. patent judges will soon hear oral arguments to decide the issue.
Read more: http://www.npr.org/sections/health-shots/2016/12/05/504454201/scientists-battle-in-court-over-lucrative-patents-for-gene-editing-tool?source=Snapzu